Elsevier.com | MedConnect.com.au | Medconnect.com.sg | Lancet.cn | JOA中文版

诊疗指南

改善HIV感染者获得并持续治疗的能力及抗逆转录病毒治疗依从性的指南

Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV
来源:MDC 2012-06-21 16:02 点击次数:111发表评论

Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence of drug resistance. The International Association of Physicians in AIDS Care convened a panel to develop evidence-based recommendations to optimize entry into and retention in care and ART adherence for people with HIV.

Methods: A systematic literature search was conducted to produce an evidence base restricted to randomized, controlled trials and observational studies with comparators that had at least 1 measured biological or behavioral end point. A total of 325 studies met the criteria. Two reviewers independently extracted and coded data from each study using a standardized data extraction form. Panel members drafted recommendations based on the body of evidence for each method or intervention and then graded the overall quality of the body of evidence and the strength for each recommendation.

Recommendations: Recommendations are provided for monitoring entry into and retention in care, interventions to improve entry and retention, and monitoring of and interventions to improve ART adherence. Recommendations cover ART strategies, adherence tools, education and counseling, and health system and service delivery interventions. In addition, they cover specific issues pertaining to pregnant women, incarcerated individuals, homeless and marginally housed individuals, and children and adolescents, as well as substance use and mental health disorders. Recommendations for future research in all areas are also provided.

The availability of potent antiretroviral therapy (ART) has resulted in remarkable decreases in HIV-related morbidity and mortality in the past 15 years (1 - 2). Entry into and retention in HIV medical care is critical to the provision of ART, and adherence to ART is among the key determinants of HIV treatment success (3 - 6). More than 2 decades of targeted research in these areas has produced a varied and complex evidence base that, to date, has not been fully evaluated or distilled into concrete recommendations for how to best monitor or support HIV care and ART adherence.

Recent data from the U.S. Centers for Disease Control and Prevention reveal that only 28% of persons with HIV in the United States have achieved viral suppression (7). Of those who knew they had HIV, only 69% were linked to care, and only 59% were retained in care (8). These figures and comparable global data (9 - 10) challenge us to explore best practices for improving entry into and retention in care on a global scale. Only with successful care linkage and retention can ART be accessed. Once patients are in care and are receiving treatment, high levels of adherence are required to prevent the selection of resistance mutations and subsequent virologic failure (11). In a global pooled sample of 33 199 adults taking ART in over 84 observational studies, only 62% of persons achieved adherence of at least 90% of doses (12). These data underscore the need for concise and clear evidence-based recommendations to help care providers monitor and support ART adherence.

In this context, the International Association of Physicians in AIDS Care (IAPAC) convened an expert panel to develop evidence-based recommendations to optimize entry into and retention in care and ART adherence and to monitor these processes. Members of the panel are listed in Appendix 1. These guidelines aim to define best practices that can be used by practitioners and health systems to improve adherence and, in turn, health outcomes. Our recommendations are based on the best published science; however, the evidence base remains insufficient in many areas. For that reason, we also highlight areas in which additional research is needed to inform future recommendations. We realize that implementation of these recommendations may, in some cases, require that new resources be identified to bring the benefit of best practices to our clinic populations. We believe that presenting recommendations based on rigorous science is the best avenue to achieve that end.

全文地址:
学科代码:内科学 传染病学   关键词:抗逆转录病毒治疗依从性
文章来源:MDC
MDC介绍: MD Consult 是爱思唯尔公司于1997年推出的新一代智慧型医学咨询平台,包含50多部著名医学参考书,88种全文医学期刊和北美临床系列杂志,10000篇患者手册,1000份诊疗指南,以及持续更新的药品信息,医学新闻,并支持PDA功能,为医生解答医学及科研问题,让医生紧贴第一手医学发展信息,并迅速以其优质的内容和方便时效的服务赢得了很高的声誉。 请点击申请试用并填写联系信息,我们将每月为前100位申请者发送带有用户名、密码及网页链接的电子邮件,请您注意查收!感谢您的参与及使用!请点击此处登录MD Consult。。马上访问MDC网站:http://www.mdconsult.com/
顶一下(0
您可能感兴趣的指南
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录
      友情链接: 中文版柳叶刀 | MD CONSULT | Journals CONSULT | Procedures CONSULT | eClips CONSULT  | Imaging CONSULT  
        好大夫   |  医师网  | 丁香园  | 论文吧  | 世界医学书库  | 好医生论坛  |  医心网  | 环球医学  | 白天使  | 医脉通 
      中华外科杂志  | 中国妇产科网  |  新青年麻醉论坛  | 杏树林  | 医学论坛网  | 春雨掌上医生  |协和青年之家